Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis Patients

NCT00973453 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Allergic Rhinoconjunctivitis

Interventions

DRUG: PURETHAL Mites 20,000 AUeq/ml
DRUG: PURETHAL Mites 20,000 AUeq/ml
DRUG: PURETHAL Mites 20,000 AUeq/ml

Sponsor

HAL Allergy